Navigation Links
Hiker without Human Heart Receives Heart Transplant 607 Miles Later
Date:11/15/2012

TUCSON, Ariz., Nov. 15, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that avid hiker Chris Marshall, who received the SynCardia temporary Total Artificial Heart in February, has been successfully bridged to a heart transplant at University of Washington (UW) Medical Center in Seattle.

(Photo: http://photos.prnewswire.com/prnh/20121115/LA13969)  

Watch video from NBC Seattle -

http://www.syncardia.com/News/avid-hiker-with-total-artificial-heart-receives-transplant.html

"I walked 607 miles with the Total Artificial Heart, so I was really fit going into that surgery," said Mr. Marshall, who received his heart transplant on Sept. 12. "That's very different from a lot of people who go into the transplant really sick. After the surgery, they not only have to recover from the transplant, but also from being sick for so long leading up to it."

Mr. Marshall was implanted with the SynCardia Total Artificial Heart on Feb. 6. Seven weeks later, on March 21, he became the first Total Artificial Heart patient in the Pacific Northwest to be discharged from the hospital using the Freedom® portable driver to power his Total Artificial Heart. After his discharge, Mr. Marshall hiked daily in the Seattle area with his wife Kathy and their golden retriever Gracie.

When asked what advice he has for other Total Artificial Heart patients, Mr. Marshall said, "Don't go home and stay cooped up. You need to get out and take advantage of the time you have to get in shape to prepare for the transplant surgery and live life. Some people are afraid. The only thing they want to do is be home or go to the clinic for visits, but for me, that's not living life."

In 1999, Mr. Marshall was diagnosed with cardiomyopathy, a disease that destroys the heart muscle over time, and ventricular tachycardia, an irregular, fast heartbeat. Although his implanted defibrillator shocked his heart 30 times over a 12-year span, Mr. Marshall never let his heart condition slow him down. He continued to hike three to five miles daily, despite his ejection fraction being only 20%.

However, last fall, he started experiencing shortness of breath while hiking on level ground, which had never happened before. On Jan. 23, Mr. Marshall and his wife Kathy traveled from their home in Wasilla, Alaska, to Seattle for what was supposed to be a one-day heart evaluation. Doctors discovered his heart was functioning at less than 10 percent, and didn't think he would survive the flight home.

Mr. Marshall was not a candidate for a left ventricular assist device (LVAD) - a mechanical pump that supports only the left side of the heart - because the right side of his heart was too weak. His doctors decided the SynCardia Total Artificial Heart was his only option for survival.

Weighing 13.5 pounds (~6 kg), the Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart. The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

Read article in The Seattle Times - http://seattletimes.com/html/localnews/2019139640_hearttransplant13m.html

View press release from UW Medical Center - http://www.washington.edu/news/2012/09/13/after-months-on-portable-artificial-heart-alaska-man-receives-transplant/

CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.

Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 1,000 implants of the Total Artificial Heart, accounting for more than 270 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

 

 


'/>"/>
SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
2. LIVE VIA SATELLITE: Physician Demonstrates New Medical Technology to Combat Back Pain without Major Surgery
3. Man Without Human Heart Hikes More Than 400 Miles
4. Homecare Community Dismayed that Medicare Will Start Prior Authorization for Wheelchairs without a Clinical Template for Physicians to Document Need
5. RMANJ Research Demonstrates That Egg Freezing Prior To IVF Yields Positive Outcomes Without Increasing Risk Of Aneuploidy
6. Mount Sinai Medical Center 1st in Tri-State Area to Discharge Patient without Human Heart
7. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
8. SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing
9. Global Human Vaccines Industry
10. ReproCELL Launches Alzheimers Disease Model Based on iPS-derived Human Neuronal Cells
11. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  Ethicon* today ... Medical, Inc., a privately held medical device company ... System for the surgical treatment of Gastroesophageal Reflux ... strategy of expanding its portfolio of minimally invasive ... medical conditions. Financial terms of the transaction have ...
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 23, 2017  A new genetic test has ... of individuals who carry HLA-B*15:02 and ... yet potentially deadly side effect of certain medications ... gene HLA-B*15:02 is strongly associated with ... syndrome and toxic epidermal necrolysis in patients treated ...
Breaking Medicine Technology:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... of SmartBen NOW, an innovative mobile app and centralized benefits dashboard solving one ... critical information securely from multiple locations. For the first time, employees can access ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home ... world to manage stress and anxiety. , “Buzzies change the way we interact ... co-founder of Buzzies. , Since its launch date in December 2016, The TouchPoint Solution ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... According to the National ... sleep is likely not the only cause of the sunken-eye look, which can include ... look older or in poor health are likely due to genetics, dehydration, allergies, and ...
(Date:3/23/2017)... El Segundo, CA (PRWEB) , ... March 23, ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. ... primary source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are ...
Breaking Medicine News(10 mins):